Upregulation of PD-L1 is associated with a large tumor size and high tumor grade (13, 14), but it is also associated with improved prognosis in basal tumors or triple-negative breast cancer (12, 13). This evidence concerns the gene CD274 and triple-negative breast carcinoma.